Catalyst Pharmaceuticals Crashes 50% Following 'Refusal To File' Letter From FDA
February 17, 2016 at 10:16 AM EST
Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) lost nearly half of its value Wednesday morning after the company disclosed it ...